AMBAC Financial Group

Ambac Financial Group announces it will rebrand as Octave Specialty Group; trading under the new ticker symbol OSG begins on November 20, 2025. The company is selling its traditional financial guarantee business, building a platform for specialty insurance and intends to acquire MGAs in the US, the UK and Bermuda. Ambac recently completed the acquisition of ArmadaCare; over the last twelve months the company reported a loss of $0.75 per share on revenue of $257.88 million. The stock trades at $8.69 with analyst targets between $10 and $19, and InvestingPro rates its financial health as moderate. » More on de.investing.com

Third Avenue Small-Cap Value Fund highlighted Ambac Financial Group in its Q3 2025 investor letter after Wisconsin regulators approved the sale of Ambac’s legacy financial guarantee business to Oaktree, enabling a rapid closing and significant cash inflow. The fund says Ambac’s balance sheet will begin to reflect its go‑forward business, and Ambac immediately announced a $250 million purchase of supplemental health manager ArmadaCare from SiriusPoint, funded largely with sale proceeds. Third Avenue initiated its position in Ambac in Q4 2024; Ambac shares closed at $8.28 on Nov. 5, 2025, with a one‑month return of 3.11% and a 52‑week decline of 26.73%. » More on finance.yahoo.com

Ambac has completed the acquisition of ArmadaCare from SiriusPoint; ArmadaCare will continue to operate as a wholly owned subsidiary under its own brand and the existing management, including CEO Ed Walker, will remain in place. Ambac says the acquisition strengthens its financial profile, diversifies its distribution platform and complements its accident and health insurance business. Financial details of the transaction were not disclosed in the statement. » More on de.investing.com